Skip to content

Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00457717
Enrollment
60
Registered
2007-04-06
Start date
2005-07-31
Completion date
2006-07-31
Last updated
2007-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

myopia, auricular acupoint, atropine, RCT

Brief summary

This study was designed to compare the difference of using atropine eyedrops alone from atropine combined with the stimulation of auricular acupoints therapy in reducing myopia progression.

Detailed description

A total of 64 school-aged children with myopia, fulfilling eligibility criteria, were recruited. They were randomly assigned to three arms: 1. 21 treated with the 0.25 % atropine each night (0.25A). 2. 20 treated with the 0.5 % atropine each night (0.5A). 3. 23 treated with 0.25 % atropine each night together with stimulation of auricular acupoints(0.25A+E). This protocol was proceeded for at least 6 months.The differences in post-treatment effects of these three groups were statistically accessed.

Interventions

DRUG0.25 % atropine
DRUG0.5 % atropine
PROCEDURE0.25 % atropine+auricular acupoints

Sponsors

China Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
6 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* all included patients, age from 6 to 15 years, had myopia (spherical equivalent \> -0.5 D) after cycloplegic refraction, * The astigmatism and anisometropia were less than 2.0 D, * IOP was less than 21 mmHg.

Exclusion criteria

* the presence of related disease such as infection, ulceration, eyelid disease, ocular and auricular disorders, * individuals with amblyopia or strabismus, * individuals received any other therapies in the period of study, * individuals suffering some sort of haemostasis disorder, * individuals did not follow the treatment (eyedrops and/or stimulation of auricular acupoints) over seven days

Design outcomes

Primary

MeasureTime frame
the progression of myopia degree, axial length elongation of eye

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026